Skip to content
  • Medicine prices at risk under Pacific trade draft: critics

    Reuters - 10/16/2014

    The U.S. experience, where generic drugs made up 85 percent of the market, showed that high IP standards were compatible with “fulsome access to medicines,” said Mark Elliot from the U.S. Chamber of Commerce’s Global Intellectual Property Center.

    But Northeastern University law professor Brook Baker said there were several proposals in the draft which would prevent marketing of generic drugs and make it easier for drug companies to get follow-on patents for small changes to or new uses of existing medicines.

    “The disclosed TPP text is a bonanza for Big Pharma and a disaster for patients everywhere,” he said.

  • Cookies on Northeastern sites

    This website uses cookies and similar technologies to understand your use of our website and give you a better experience. By continuing to use the site or closing this banner without changing your cookie settings, you agree to our use of cookies and other technologies. To find out more about our use of cookies and how to change your settings, please go to our Privacy Statement.